BERKELEY, Calif.--(BUSINESS WIRE)--Channel Medsystems, Inc., a medical device company whose mission is to empower every woman to take control of her health journey, today announced that the first ...
SAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Channel Medsystems, a commercial-stage women's health company, announced today that more than 5,000 women have now been treated with the Cerene® ...
MIAMI, March 16, 2026 (GLOBE NEWSWIRE)-- Lucia Gaitan, M.D., FACOG is the first physician in Miami to offer the Cerene® Endometrial Cryotherapy device, expanding access to a minimally invasive ...
BERKELEY, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Channel Medsystems’ Cerene® Cryotherapy is proud to announce the launch of its Know Your Flow Event Series focused on making menstrual and ...
Channel Medsystems announced that the FDA has approved the Cerene Cryotherapy Device for the treatment of heavy menstrual bleeding. Channel Medsystems announced that the Food and Drug Administration ...
BERKELEY, Calif., Aug. 20, 2026 (GLOBE NEWSWIRE) -- Channel Medsystems, Inc., a privately held medical technology company dedicated to raising the standard of care for women with heavy menstrual ...
Channel Medsystems closed a series C-1 financing of $14.1 million led by insider investors. The company has developed a the Cerene physician-office cryotherapy device for heavy menstrual bleeding.
Dr. Felix Cohen, M.D., FACOG, Medical Director of Cohen Medical Practice in New York City, is providing women of Queens who suffer from abnormal uterine bleeding and dysmenorrhea with access to ...
The First Two Events Will Take Place in New York and Charlotte BERKELEY, Calif., July 08, 2026 (GLOBE NEWSWIRE) -- Channel Medsystems’ Cerene® Cryotherapy is proud to announce the launch of its Know ...
The MarketWatch News Department was not involved in the creation of this content. MIAMI, March 19, 2026 (GLOBE NEWSWIRE) -- In a release issued under the same headline on March 16, 2026 by Channel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results